会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 21. 发明授权
    • N-aroyl piperazine derivatives as orexin receptor antagonists
    • N-芳酰哌嗪衍生物作为食欲素受体拮抗剂
    • US07166608B2
    • 2007-01-23
    • US10492250
    • 2002-10-09
    • Clive Leslie BranchChristopher Norbert JohnsonDavid John NashGeoffrey Stemp
    • Clive Leslie BranchChristopher Norbert JohnsonDavid John NashGeoffrey Stemp
    • A61K31/496C07D413/06C07D417/06
    • C07D413/10C07D241/04C07D417/06
    • This invention relates to N-aroyl piperazine derivatives of formula (I), wherein: Y represents NR2; m represents 1, 2 or 3; p represents 0 or 1; X is O, S, C═O, SO2, or CH═CH—; Ar1 is aryl, or a mono or bicyclic heteroaryl group containing up to 4 heteroatoms selected from N, O and S; any of which may be optionally substituted; Ar2 represents phenyl or a 5- or 6-membered heterocyclyl group containing 1 to 3 heteroatoms selected from N, O and S, wherein the phenyl heterocyclyl group is substituted by R1 and further optional substituents; or Ar2 represents an optionally substituted bicyclic aromatic or bicyclic heteroaromatic group containing 1 to 4 heteroatoms selected from N, O and S; R1 represents optionally substituted (C1-4)alkoxy, halo, optionally substituted (C1-6)alkyl, optionally substituted phenyl, or an optionally substituted 5- or 6-membered heterocyclic ring containing 1 to 4 heteroatoms selected from N, O and S; R2 represents hydrogen, optionally substituted (C1-4)alkyl, optionally substituted (C1-6)alkanoyl, optionally subtituted (C1-6)alkanoxycarbonyl or optionally substituted aryl(C1-6)alkyloxycarbonyl; and their use as orexin receptor-antagonists.
    • 本发明涉及式(I)的N-芳酰基哌嗪衍生物,其中:Y表示NR 2; m表示1,2或3; p表示0或1; X是O,S,C-O,SO 2 H或CH-CH-; Ar 1是芳基或含有至多4个选自N,O和S的杂原子的单或双环杂芳基; 任何一个可以任选地被取代; Ar 2表示苯基或含有1至3个选自N,O和S的杂原子的5-或6-元杂环基,其中苯基杂环基被R 1 O取代 和另外任选的取代基; 或者Ar 2表示含有1至4个选自N,O和S的杂原子的任选取代的双环芳族或双环杂芳族基团; R 1表示任选取代的(C 1-4 - )烷氧基,卤素,任选取代的(C 1-6 - )烷基,任选取代的苯基, 或含有1至4个选自N,O和S的杂原子的任选取代的5或6元杂环; R 2表示氢,任选取代的(C 1-4 - )烷基,任选取代的(C 1-6 - )烷酰基,任选取代的(C 烷氧基羰基或任选取代的芳基(C 1-6 - )烷氧基羰基; 以及它们作为食欲肽受体拮抗剂的用途。
    • 25. 发明授权
    • Piperdines for use as orexin receptor antagonists
    • 用作食欲肽受体拮抗剂的Pi子
    • US06677354B2
    • 2004-01-13
    • US10311445
    • 2002-12-16
    • Clive Leslie BranchChristopher Norbert JohnsonGeoffrey StempKevin Thewlis
    • Clive Leslie BranchChristopher Norbert JohnsonGeoffrey StempKevin Thewlis
    • A61K314545
    • C07D401/06C07D211/26C07D401/10C07D405/06C07D405/10C07D405/14C07D409/14C07D413/10C07D413/14C07D417/06C07D417/14C07D471/04
    • Disclosed are compounds of formula (I): wherein: Y represents a group (CH2)n, wherein n represents 0, 1 or 2; R1 is phenyl, naphthyl, a mono or bicyclic heteroaryl group containing up to 3 heteroatoms selected from N, O and S; or a group NR3R4 wherein one of R3 and R4 is hydrogen or optionally substituted (C1-4)alkyl and the other is phenyl, naphthyl or a mono or bicyclic heteroaryl group containing up to 3 heteroatoms selected from N, O and S, or R3 and R4 together with the N atom to which they are attached form a 5 to 7-membered cyclic amine which has an optionally fused phenyl ring; any of which R1 groups may be optionally substituted; R2 represents phenyl or a 5- or 6-membered heteroaryl group containing up to 3 heteroatoms selected from N, O and S, wherein the phenyl or heteroaryl group is substituted by R5, and further optional substituents; or R2 represents an optionally substituted bicyclic aromatic or bicyclic heteroaromatic group containing up to 3 heteroatoms selected from N, O and S; R5 represents an optionally substituted (C1-4)alkoxy, halo, optionally substituted (C1-6)alkyl, optionally substituted phenyl, or an optionally substituted 5- or 6-membered heterocyclic ring containing up to 3 heteroatoms selected from N, O and S; or pharmaceutically acceptable salts thereof.
    • 公开了式(I)的化合物:其中:Y表示基团(CH 2)n,其中n表示0,1或2; R 1是苯基,萘基,含有至多3个选自杂原子的单或双环杂芳基 来自N,O和S; 或NR 3或R 4基团,其中R 3和R 4中的一个是氢或任选取代的(C 1-4)烷基,另一个是苯基,萘基或含有上述的单或双环杂芳基 至3个选自N,O和S的杂原子,或R 3和R 4与它们所连接的N原子一起形成具有任选稠合的苯环的5至7元环胺; 任何R 1可以任选被取代; R 2表示苯基或含有至多3个选自N,O和S的杂原子的5-或6-元杂芳基,其中苯基或杂芳基被取代 R 5和另外任选的取代基; 或R 2表示含有至多3个选自N,O和S的杂原子的任选取代的双环芳族或双环杂芳族基团; R 5表示任选取代的(C 1-4)烷氧基,卤素,任选取代的(C1- 6)烷基,任选取代的苯基或含有至多3个选自N,O和S的杂原子的任选取代的5或6元杂环; 或其药学上可接受的盐。